NCT01339221
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium No drug interventions Not Available Not Available completed NCT02914184
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks prevention 3 completed NCT03954743
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks prevention 3 completed NCT01107587
Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants prevention 1 completed NCT02153333
Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™ No drug interventions Not Available Not Available completed NCT00329745
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210) prevention 3 completed NCT00969228
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants prevention 4 completed NCT00750893
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants Not Available Not Available completed NCT01915888
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination No drug interventions Not Available Not Available completed NCT00533507
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age prevention 3 completed NCT00345956
To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam) prevention 3 completed NCT00134732
Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis prevention 3 completed NCT00875641
Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States No drug interventions Not Available Not Available completed NCT00480324
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants prevention 3 completed NCT00420316
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. prevention 3 completed NCT01171963
Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants prevention 3 completed NCT00140686
To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines prevention 3 completed NCT01636739
Special Drug Use Investigation for ROTARIX® Not Available Not Available completed NCT00263666
A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa prevention 2 completed NCT00140673
A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. prevention 3 completed NCT00938327
Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants Not Available Not Available completed NCT01435967
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™ No drug interventions Not Available Not Available completed NCT00729001
Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. prevention 2 completed NCT00382772
A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine). prevention 3 completed NCT01563146
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007 No drug interventions Not Available Not Available completed NCT01978223
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis No drug interventions Not Available Not Available withdrawn NCT01592838
Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium No drug interventions Not Available Not Available completed NCT00383903
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa No drug interventions prevention 2 completed NCT01162590
Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults prevention 1 completed NCT00779779
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants Not Available Not Available completed NCT00139347
Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants prevention 3 completed NCT00363545
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants) prevention 3 completed NCT00420745
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants prevention 3 completed NCT00653198
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama No drug interventions Not Available Not Available completed NCT01682005
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination No drug interventions Not Available Not Available completed NCT01636193
Drug Use Investigation for ROTARIX® Not Available Not Available completed NCT00334607
Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA prevention 3 completed NCT00425737
Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants prevention 2 completed NCT01563159
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011 No drug interventions Not Available Not Available completed NCT00757770
Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine prevention 3 completed NCT01733849
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia No drug interventions Not Available Not Available completed NCT01086436
Study to Evaluate the Safety of Rotarix™ in Chinese Children prevention 1 completed NCT00370318
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines prevention 3 completed NCT00139334
A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh prevention 2 completed NCT00137930
Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis prevention 2 completed NCT00396630
A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family. prevention 3 completed NCT01177826
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children No drug interventions Not Available Not Available completed NCT00353366
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination Not Available Not Available completed NCT00385320
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months No drug interventions prevention 2 completed NCT01733862
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis No drug interventions Not Available Not Available completed NCT00432380
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. prevention 2 completed NCT01110044
Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine prevention 2 withdrawn NCT00241644
Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants prevention 3 completed NCT01253967
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania No drug interventions Not Available Not Available completed NCT00489567
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden No drug interventions Not Available Not Available completed NCT00289172
Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India prevention 3 completed NCT01198769
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. prevention 4 completed NCT00197210
A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants prevention 3 completed NCT00090233
Rotavirus Efficacy and Safety Trial (REST)(V260-006) prevention 3 completed NCT03870061
Evaluation of an Infant Immunization Encouragement Program in Nigeria No drug interventions prevention Not Available completed NCT03313128
SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance No drug interventions Not Available Not Available recruiting NCT02538211
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses prevention Not Available completed NCT00092456
Consistency Lots Vaccine Study (V260-009) prevention 3 completed NCT01467037
Vaccine Effectiveness of RV1 in a Naïve Population No drug interventions Not Available Not Available completed NCT03367559
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam prevention 3 unknown_status NCT06080906
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine No drug interventions prevention 2 recruiting NCT06485258
CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults prevention 1 recruiting NCT05212935
A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy Not Available Not Available unknown_status NCT05037435
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. prevention 3 completed NCT02220439
Does the Fecal Microbiome Influence Rotarix Immunogenicity No drug interventions Not Available Not Available completed NCT00757926
Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants prevention 1 / 2 withdrawn NCT01357174
ROTATEQ™ Post-Marketing Surveillance in the Philippines No drug interventions Not Available Not Available terminated NCT00346892
To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV prevention 2 completed NCT00981669
Rotavirus Vaccine Produced by Butantan Institute prevention 1 completed NCT00443846
RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) prevention 3 completed NCT00092443
Dose Confirmation Efficacy Study (V260-007) prevention 3 completed NCT00280111
Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants No drug interventions prevention 1 completed NCT00130832
Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) treatment 3 completed NCT00484952
Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel No drug interventions Not Available Not Available unknown_status NCT03483116
A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine No drug interventions prevention 2 completed NCT01363726
Surveillance of Rotavirus Gastroenteritis in Children <5 Years No drug interventions Not Available Not Available unknown_status NCT02542462
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study other 4 completed NCT05621655
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers prevention 2 active_not_recruiting NCT01511133
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™ No drug interventions Not Available Not Available completed NCT00981877
Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children treatment Not Available completed NCT01764256
A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine prevention 1 completed NCT04626856
Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection No drug interventions prevention 1 unknown_status NCT01328925
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children treatment 2 completed NCT00683982
Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus treatment Not Available completed NCT05032391
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization prevention 3 completed NCT00880698
Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers treatment 2 completed NCT02992197
The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity prevention 4 completed NCT00895492
Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile No drug interventions Not Available Not Available completed NCT00302640
Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children treatment 2 / 3 completed NCT01266850
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules prevention 4 completed NCT03207750
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine prevention 3 completed NCT02662543
The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines No drug interventions Not Available Not Available unknown_status